6:00 PM – 6:30 PM (ET)
5:00 PM – 5:30 PM (CT)
4:00 PM – 4:30 PM (MT)
3:00 PM – 3:30 PM (PT)
Chronic obstructive pulmonary disorder (COPD) is a complex and heterogeneous disease that is associated with significant morbidity and mortality. Despite efforts to standardize the diagnosis, treatment, and management of this progressive disease, clinical practice has consistently underdiagnosed and undertreated this condition. As a result, patients with COPD continue to be associated with a poor quality of life, and there has remained an unmet need to improve its continuum of care. Recent literature, GOLD reports, pharmacotherapy recommendations, and the SARS-CoV-2 pandemic have created opportunities for improved care and questions on clinical implementation. This program will provide a brief overview of recent developments and recommendations related to COPDGene. We encourage you to bring your pressing questions to this expert faculty led discussion.
Ruth Tal-Singer, PhD
President and Chief Scientific Officer
COPD Foundation
Washington, District of Columbia
President, TALSi Translational Medicine Consulting, LLC
Greater Philadelphia, Pennsylvania
This educational activity has been designed for pulmonologists and other clinicians involved in the management of patients with COPD.
Upon completion of this educational activity, participants should be able to:
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Integrity Continuing Education, Inc. designates this live activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to receive credit for this activity, the participant must view the live webcast and complete the evaluation form at the end of the program. A statement of credit will be issued only upon submission of a completed activity evaluation form and will be sent to you within four weeks of receipt of the completed evaluation.
There is no fee for this educational activity.
Pre-registration is encouraged to reserve your spot
For more information or to pre-register call Integrity Continuing Education at 1-855-835-4004
Integrity Continuing Education requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Ruth Tal-Singer, PhD
Former employee and current shareholder of GSK and reports personal fees from VOCALISHEALTH, ImmunoMet, and Ena Respiratory.
Integrity Continuing Education planners and managers (along with their spouses/life partners) reported no financial relationships nor relationships to products or devices with commercial interests related to the content of this CME activity.
When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)
Click here for more information on minimum system requirements.
The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Provided by Integrity Continuing Education, Inc.
This activity is supported by an independent educational grant from AstraZeneca
Please use the link below to access the live webcast on the day of the event.